Clinical Trial Update: Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

View source ↗

Summary

Completed safety and surveillance study of ustekinumab using the Ingenix NHI database in psoriasis. The update summarizes safety surveillance findings from the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Janssen Biotech, Inc. | Conditions: Psoriasis | Status: COMPLETED